CLINICAL TRIALS PROFILE FOR METHYLPREDNISOLONE ACETATE

All Clinical Trials for METHYLPREDNISOLONE ACETATE

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00185692 ↗	Allogeneic Transplantation From Related Haploidentical Donors	Completed	Stanford University	Phase 2	2000-08-01	The purpose of the study is to evaluate the feasibility and safety of transplanting CD34+ selected hematopoietic cells from a haploidentical related donor following a nonmyeloablative regimen of total lymphoid irradiation (TLI) and antithymocyte globulin (ATG).
NCT00290589 ↗	A Trial of Corticosteroids for Low Back Pain	Completed	Montefiore Medical Center	Phase 3	2003-06-01	Low back pain is a common symptom that functionally disables many people. When the low back pain is accompanied by pain that shoots down the leg, it is felt to be caused by a herniated disc. We are conducting this study to determine if a powerful anti-inflammatory agent will decrease the pain and functional impairment that is associated with this illness.
NCT00492973 ↗	Do Corticosteroid Injections During Total Knee Replacement Improve Early Clinical Results?	Completed	St. Joseph's Health Care London	N/A	2006-03-01	Prior to surgery, a pharmacist will randomly assign participating patients to one of two groups. One group will get an injection in the knee during surgery that contains medications to limit pain and an antibiotic. A second group will get an injection in the knee during surgery that contains the same pain medications and antibiotic along with a corticosteroid to control inflammation. Corticosteroids are anti-inflammatory medications, not to be confused with muscle-building anabolic steroids you may have heard about in the news. Each patient will have an equal chance of being in either of the two groups. This study will test the safety and efficacy of methylprednisolone acetate in the treatment of pain and inflammation following total knee replacement.
NCT00492973 ↗	Do Corticosteroid Injections During Total Knee Replacement Improve Early Clinical Results?	Completed	New Lexington Clinic	N/A	2006-03-01	Prior to surgery, a pharmacist will randomly assign participating patients to one of two groups. One group will get an injection in the knee during surgery that contains medications to limit pain and an antibiotic. A second group will get an injection in the knee during surgery that contains the same pain medications and antibiotic along with a corticosteroid to control inflammation. Corticosteroids are anti-inflammatory medications, not to be confused with muscle-building anabolic steroids you may have heard about in the news. Each patient will have an equal chance of being in either of the two groups. This study will test the safety and efficacy of methylprednisolone acetate in the treatment of pain and inflammation following total knee replacement.
NCT01037907 ↗	A Study of Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)	Terminated	BTG International Inc.	Phase 2	2009-11-01	To determine the efficacy and safety of an oral drug (BGC20-0134) in patients with relapsing remitting multiple sclerosis. Specifically, the cumulative number of new gadolinium enhancing lesions after 24 weeks of treatment with BGC20-0134.
NCT01132677 ↗	A Study Comparing Viscosupplementation and Corticosteroid Injections for Knee Osteoarthritis	Unknown status	LifeMark Health	N/A	2010-05-01	Do differences exist between patients who receive a single intra-articular injection of corticosteroid versus patients who receive a single intra-articular injection of hyaluronic acid for the treatment of knee osteoarthritis at 1, 3 and 6 weeks, and 3 and 6 months post injection?
NCT01144143 ↗	Treatment Of Knee Osteoarthritis With Intra-Articular Infliximab	Completed	Centocor, Inc.	Phase 4	2007-07-01	The purpose of this study is to determine if an anti-inflammatory drug, called infliximab, will reduce inflammation in the synovial lining in patients with an early stage of osteoarthritis of the knee. It will also help determine if the study medication decreases the accumulation of synovial fluid and prevents cartilage breakdown.

Clinical Trial Conditions for METHYLPREDNISOLONE ACETATE

Condition Name

Condition Name for METHYLPREDNISOLONE ACETATE
Intervention	Trials
Osteoarthritis, Knee	2
Knee Arthroplasty	2
Total Knee Replacement	2
Sciatica	2

Condition MeSH

Condition MeSH for METHYLPREDNISOLONE ACETATE
Intervention	Trials
Osteoarthritis	5
Syndrome	4
Intervertebral Disc Degeneration	3
Low Back Pain	3

Clinical Trial Locations for METHYLPREDNISOLONE ACETATE

Trials by Country

Trials by Country for METHYLPREDNISOLONE ACETATE
Location	Trials
United States	22
Egypt	3
Canada	2
Israel	2
Spain	2

Trials by US State

Trials by US State for METHYLPREDNISOLONE ACETATE
Location	Trials
New York	5
Ohio	3
Texas	3
Connecticut	2
Kansas	2

Clinical Trial Progress for METHYLPREDNISOLONE ACETATE

Clinical Trial Phase

Clinical Trial Phase for METHYLPREDNISOLONE ACETATE
Clinical Trial Phase	Trials
Phase 4	14
Phase 3	3
Phase 2/Phase 3	1

Clinical Trial Status

Clinical Trial Status for METHYLPREDNISOLONE ACETATE
Clinical Trial Phase	Trials
Completed	16
Not yet recruiting	5
Recruiting	5

Clinical Trial Sponsors for METHYLPREDNISOLONE ACETATE

Sponsor Name

Sponsor Name for METHYLPREDNISOLONE ACETATE
Sponsor	Trials
National Institute for Health Research, United Kingdom	2
Hadassah Medical Organization	2
Department of Anesthesiology Faculty Development Fund	2

Sponsor Type

Sponsor Type for METHYLPREDNISOLONE ACETATE
Sponsor	Trials
Other	55
Industry	9